Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2023
Mechanisms and treatment approaches for ACLFSalvatore Piano, Nadim Mahmud, Paolo Caraceni, et al.Advanced Biology|January 28, 2024
Antioxidant Microgels Support Peroxide-Challenged Hepatic CellsIsabella Nymann Westensee, Karen Louise Thomsen, Rajeshwar Prosad Mookerjee, et al.Metabolic Brain Disease|November 3, 2022
The role of brain inflammation and abnormal brain oxygen homeostasis in the development of hepatic encephalopathyAnne Catrine Daugaard Mikkelsen, Karen Louise Thomsen, Rajeshwar Prosad Mookerjee, et al.Neurochemical Research|March 1, 2022
Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical EvidenceAnne Catrine Daugaard Mikkelsen, Kristoffer Kjærgaard, Rajeshwar Prosad Mookerjee, et al.Angewandte Chemie (International Ed. in English)|June 11, 2026
A Lipid-Conjugation Strategy for Intracellular Reactive Oxygen Species Control in Hepatic CellsOlav Vestrheim, Huichao Zhao, Anders Bodholt Nielsen, et al.Small (Weinheim an Der Bergstrasse, Germany)|July 1, 2024
Engineered Lipids for Intracellular Reactive Oxygen Species Scavenging in Steatotic HepatocytesIsabella N Westensee, Paula de Dios Andres, Edit Brodszkij, et al.NMR in Biomedicine|October 8, 2020
Liver perfusion MRI in a rodent model of cirrhosis: Agreement with bulk-flow phase-contrast MRI and noninvasive evaluation of inflammation in chronic liver disease using flow-sensitive alternating inversion recovery arterial spin labelling and tissue T1Manil Dinesh Chouhan, Rajiv Ramasawmy, Alan Bainbridge, et al.Journal of Clinical Medicine|February 12, 2021
Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and PerspectivesKristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Charlotte Wilhelmina Wernberg, et al.JHEP Reports : Innovation in Hepatology|February 28, 2024
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammationKristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Anne M Landau, et al.JHEP Reports : Innovation in Hepatology|June 9, 2026
Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver diseaseKaren Louise Thomsen, Vikram Sharma, Helen Jones, et al.Pageof 2